Mounjaro®
Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
- ~22.5% average body weight loss
 - Significant weight reduction
 - Improves blood sugar levels
 - Clinically proven weight loss
 

How long can Saxenda be left unrefrigerated? Once in use, Saxenda (liraglutide) can be stored at room temperature for up to 30 days, provided the temperature remains below 30°C. This GLP-1 receptor agonist, licensed in the UK for weight management, requires careful storage to maintain its stability and effectiveness. Understanding proper storage guidelines is essential for patients using this biological medicine, particularly when travelling or managing daily routines. This article provides comprehensive guidance on Saxenda storage requirements, temperature limits, and practical tips to ensure your medication remains safe and effective throughout treatment.
Summary: Once in use, Saxenda can be stored unrefrigerated at room temperature (below 30°C) for up to 30 days from the date of first use.
Saxenda (liraglutide 6 mg/ml) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for weight management in adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of weight-related comorbidities. As a biological medicine, Saxenda requires specific storage conditions to maintain its stability, efficacy, and safety throughout its shelf life.
Before first use, Saxenda pens must be stored in a refrigerator at temperatures between 2°C and 8°C. The pens should be kept in their original packaging to protect them from light and should never be frozen. If a pen has been frozen, it must not be used, as freezing can damage the active protein and affect the medication's effectiveness. It is advisable to store Saxenda away from the freezer compartment and not in direct contact with refrigerator cooling elements.
After first use, the storage requirements change slightly. Once you have administered your first dose, the Saxenda pen may be stored either in the refrigerator (2°C to 8°C) or at room temperature (below 30°C) for up to 30 days. The pen cap must be kept on when not in use to protect the solution from light. During this in-use period, the pen should never be stored with the needle attached, as this can lead to contamination, leakage, or air bubbles that may affect dose accuracy.
Patients should always check the expiry date printed on the pen label and carton before use. Using Saxenda beyond its expiry date is not recommended, as the manufacturer cannot guarantee the medication's potency or safety. Always keep Saxenda out of the sight and reach of children and never share your pen with anyone else. Proper adherence to these storage guidelines ensures optimal therapeutic outcomes.

Understanding the permissible duration for unrefrigerated storage is essential for patients using Saxenda, particularly those with active lifestyles or travel commitments. According to the Medicines and Healthcare products Regulatory Agency (MHRA) approved product information, once in use, Saxenda can be kept unrefrigerated for up to 30 days, provided the temperature does not exceed 30°C.
This 30-day window begins from the moment you administer your first dose from a new pen. It is crucial to record the date of first use on the pen label to track this timeframe accurately. After 30 days, the pen must be discarded, regardless of how much medication remains, as the stability of liraglutide cannot be guaranteed beyond this period when stored at room temperature.
For unopened pens, the guidance is more stringent. Unopened Saxenda pens should always be stored in a refrigerator (2°C to 8°C). If an unused Saxenda pen is accidentally left out of the refrigerator, it should be returned to refrigeration as soon as possible. While brief periods at room temperature (such as during transport from the pharmacy) are generally acceptable, the manufacturer does not provide specific guidance on how long unopened pens can safely remain at room temperature. If you are unsure whether an unopened pen remains suitable for use after being left unrefrigerated, contact your pharmacist for advice.
Temperature fluctuations can affect the medication's stability. Avoid exposing Saxenda to temperatures above 30°C at any time, as excessive heat accelerates the degradation of the active ingredient. Similarly, never leave Saxenda in direct sunlight, near radiators, or in hot environments such as cars during warm weather. If you are uncertain whether your Saxenda has been stored correctly, it is always safer to consult your pharmacist rather than risk using potentially compromised medication.
Improper storage of Saxenda can compromise both its therapeutic effectiveness and safety profile. Liraglutide, the active ingredient in Saxenda, is a peptide hormone that is susceptible to degradation when exposed to inappropriate temperatures. When the medication is stored outside the recommended temperature range or for longer than the specified duration, the molecular structure of liraglutide may become altered, reducing its biological activity.
Reduced efficacy is the primary concern with improperly stored Saxenda. Patients may not achieve the expected appetite suppression and weight loss outcomes if the medication has degraded. This can be particularly problematic as individuals may not immediately recognise that their treatment is less effective, potentially attributing lack of progress to other factors such as diet or exercise adherence. There is no reliable way to visually determine whether Saxenda has lost potency due to storage issues.
From a safety perspective, degraded liraglutide is primarily a concern because of reduced effectiveness rather than toxicity. Additionally, if storage conditions have allowed bacterial contamination (particularly through storing with needles attached or poor aseptic technique), there is a risk of infection at injection sites.
Physical changes to the solution may indicate storage problems. Before each injection, patients should inspect the Saxenda solution, which should be clear and colourless or almost colourless. If the solution appears cloudy, discoloured, or contains particles or flakes, the pen must not be used and should be returned to the pharmacy. Such changes may indicate protein aggregation or contamination.
If you suspect your Saxenda has been stored incorrectly, do not use it. Contact your GP, pharmacist, or the healthcare professional who prescribed your medication for guidance. They can advise whether a replacement is necessary and provide counselling on proper storage techniques to prevent future issues. Any suspected side effects can be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.
Travelling with Saxenda requires advance planning to ensure the medication remains within the appropriate temperature range throughout your journey. Whether travelling domestically within the UK or internationally, maintaining proper storage conditions is essential for treatment continuity and medication safety.
For short trips (day trips or overnight stays), an insulated cool bag with ice packs may help keep Saxenda at an appropriate temperature. However, ensure the pen does not come into direct contact with ice packs, as this could cause freezing. Place a barrier, such as a cloth or bubble wrap, between the ice packs and the medication. Some pharmacies sell medication cooling wallets that can help keep pens cool for limited periods – follow the manufacturer's instructions for these products.
For longer journeys or holidays, consider the following strategies:
Air travel: Saxenda should be carried in hand luggage rather than checked baggage, as hold temperatures can drop below freezing. Carry your prescription or a letter from your GP confirming your need for the medication, as airport security may question liquids or injection devices. UK Civil Aviation Authority and Department for Transport regulations permit medications in hand luggage, but documentation facilitates the screening process. Check with your airline and destination country for specific requirements.
Accommodation storage: Upon arrival at your destination, immediately refrigerate your Saxenda if facilities are available. If refrigeration is not accessible (such as in some hotel rooms), remember that in-use pens can be kept at room temperature (below 30°C) for up to 30 days. Request a small refrigerator in your room if staying in hotels, or consider accommodation with kitchen facilities.
Hot climates: When travelling to warm destinations, be particularly vigilant about temperature exposure. Never leave Saxenda in vehicles, on windowsills, or in direct sunlight. If outdoor temperatures regularly exceed 30°C, keep the medication in the coolest available location, ideally air-conditioned spaces.
Always carry sufficient supplies for your trip duration plus a few extra days in case of travel delays. Keep Saxenda in its original packaging with the prescription label visible to facilitate customs clearance when travelling internationally.
Knowing when to discard Saxenda is crucial for maintaining treatment safety and effectiveness. Several circumstances necessitate disposal of your Saxenda pen, and adhering to these guidelines helps prevent the use of compromised medication.
Time-based disposal criteria include:
30 days after first use: Once you have used a Saxenda pen for the first time, it must be discarded after 30 days, even if medication remains. Mark the date of first use on the pen label to track this timeframe accurately.
Expiry date exceeded: Never use Saxenda beyond the expiry date printed on the label and carton, regardless of storage conditions. The expiry date refers to the last day of the stated month.
Storage-related disposal situations:
Freezing: If Saxenda has been frozen at any point, discard it immediately. Freezing damages the protein structure of liraglutide.
Excessive heat exposure: If the pen has been exposed to temperatures above 30°C for extended periods, it should be discarded. When in doubt about temperature exposure, consult your pharmacist.
Uncertain storage history: If you cannot remember when you first used a pen or are unsure about its storage conditions, it is safer to discard it and start a fresh pen.
Physical appearance concerns:
Discard Saxenda if the solution appears cloudy, discoloured, or contains particles, flakes, or crystals. The solution should always be clear and colourless or almost colourless.
If the pen appears damaged, cracked, or has been dropped, do not use it, as this may affect dose accuracy or sterility.
Proper disposal is important for environmental and safety reasons. Do not dispose of Saxenda in household waste or down drains. Return used or expired pens to your pharmacy, which operates a medicines take-back scheme. Remove the needle before returning the pen (dispose of needles in a sharps container, available from your GP surgery, community pharmacy, or local council clinical waste services, depending on local arrangements). Do not share your pen with anyone else. If you experience any unexpected symptoms or concerns about your Saxenda, contact your GP or healthcare professional promptly for advice.
If the pen is already in use (first dose administered), it can remain at room temperature below 30°C for up to 30 days total. If unopened, return it to the refrigerator promptly and contact your pharmacist if you are uncertain about its suitability for use.
Do not use Saxenda that has been frozen, as freezing damages the protein structure of liraglutide and compromises its effectiveness. Discard the pen and obtain a replacement from your pharmacy.
Carry Saxenda in hand luggage with prescription documentation, use an insulated cool bag with ice packs (avoiding direct contact), and refrigerate upon arrival if possible. In-use pens can remain at room temperature below 30°C for up to 30 days.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript